Two Sigma Investments »

Enlivex Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 11k 1.04
2020-06-30 $56k 11k 5.10

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Com Cl A (RIVN)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Lockheed Martin Corporation (LMT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Two Sigma Investments

Top funds holding Enlivex Therapeutics

Citizens Financial Group
Morgan Stanley
Renaissance Technologies
Citadel Advisors
Susquehanna International
XTX Topco
Two Sigma Securities
Sigma Investment Counselors
Jane Street
Hrt Financial
Prosperity Consulting Group
Neuberger Berman Group
Two Sigma Investments
SkyView Investment Advisors
Wells Fargo & Company

View all funds holding Enlivex Therapeutics